Territory Stories

NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)

Details:

Title

NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)

Collection

NT trends in ecstasy and related drug markets; Reports; PublicationNT

Date

2011

Description

Made available via the Publications (Legal Deposit) Act 2004 (NT).

Notes

Date:2011; Australian drug trends series No. 80

Language

English

Subject

Drug abuse surveys -- Northern Territory -- Periodicals; Ecstasy (Drug) -- Northern Territory -- Periodicals; Drug abuse -- Northern Territory -- Periodicals

Publisher name

National Drug and Alcohol Research Centre, University of New South Wales

Place of publication

Sydney (N.S.W)

ISBN

9780733430206

Copyright owner

Check within Publication or with content Publisher.

Parent handle

https://hdl.handle.net/10070/242182

Citation address

https://hdl.handle.net/10070/610318

Page content

x Glossary of Terms Cap Small amount, typically enough for one injection Half-weight 0.5 grams Illicit Illicit refers to pharmaceuticals obtained from a prescription in someone elses name, e.g. through buying them from a dealer or obtaining them from a friend or partner Indicator data Sources of secondary data used in the IDRS (see Method section for further details) Key expert(s) Also referred to as KE; persons participating in the Key Expert Survey component of the IDRS (see Method section for further details) Licit Licit refers to pharmaceuticals (e.g. methadone, buprenorphine, morphine, oxycodone, benzodiazepines, antidepressants) obtained by a prescription in the users name. This definition does not take account of doctor shopping practices; however, it differentiates between prescriptions for self as opposed to pharmaceuticals bought on the street or those prescribed to a friend or partner Lifetime injection Injection (typically intravenous) on at least one occasion in the participants lifetime Lifetime use Use on at least one occasion in the participants lifetime via one or more of the following routes of administration injecting, smoking, snorting and/or swallowing Participant In the context of this report, refers to persons who participated in the Injecting Drug User Survey (does not refer to key expert participants unless stated otherwise) People who inject Also referred to as PWID. In the context of the IDRS, refers to persons drugs participating in the Injecting Drug User Survey component of the IDRS (See Method section for further details) Point 0.1 gram although may also be used as a term referring to an amount for one injection (similar to a cap; see above) Recent injection Injection (typically intravenous) in the six months preceding interview Recent use Use in the six months preceding interview via one or more of the following routes of administration injecting, smoking, snorting and/or swallowing Use Use via one or more of the following routes of administration injecting, smoking, snorting and/or swallowing Guide to days of use/injection 180 days daily use/injection* over preceding six months 90 days use/injection* every second day 24 days weekly use/injection* 12 days fortnightly use/injection* 6 days monthly use/injection* *as appropriate


Aboriginal and Torres Strait Islander people are advised that this website may contain the names, voices and images of people who have died, as well as other culturally sensitive content. Please be aware that some collection items may use outdated phrases or words which reflect the attitude of the creator at the time, and are now considered offensive.

We use temporary cookies on this site to provide functionality.
By continuing to use this site without changing your settings, you consent to our use of cookies.